This site is intended for healthcare professionals only
LoginRegister
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsUSFDA issues EIR for Piramal Pharma Ahmedabad facility
Lalitpur Pharma ParkZydus Lifesciences gets USFDA nod for prostate cancer drug Enzalutamide
Eris LifesciencesEris Lifscience Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC
AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter MarketAbbVie seeks USFDA accelerated approval for telisotuzumab vedotin for previously treated non small...
Bad Times for Sanofi Healthcare? Market Signals Suggest Growing PressureSanofi, Regeneron get USFDA nod for Dupixent for COPD
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsUSFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults
CDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof CreamPure & Cure Healthcare gets CDSCO Panel nod to study Ferric Maltol Capsules 30 mg
Lupin rolls out constipation drug Prucalopride in US after USFDA nodUpcoming 50 pharma manufacturing plants under PLI scheme to be completed in 2 years: Centre
Alembic Pharma secures USFDA approval for Travoprost Ophthalmic SolutionAlembic Pharma receives USFDA EIR for Oral solid formulation facility (F-1) at Panelav
Language Row Costs Pharmacist: Action Ordered for Giving Wrong Medicine, Refusing BengaliDrugs in CDSCO samples Counterfeit, not ours, say leading pharma companies
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsUSFDA issues three observations each on API, Finished Product side of Lupin Pithampur facility
Lupin Manufacturing Solutions, PolyPeptide Group forge long term Peptide allianceLupin arm ink pact with Celnova for distribution of Orphan Drug NaMuscla in Argentina, Colombia
X